Author

Massimiliano di Pietro

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia
Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia

Massimiliano di Pietro  et al.

How do I recognise the pre-malignant stomach and manage the early cancer?
How do I recognise the pre-malignant stomach and manage the early cancer?

Massimiliano di Pietro

CYTOSPONGE AS A TRIAGING TOOL TO UPPER GI ENDOSCOPY DURING COVID-19 PANDEMIC
CYTOSPONGE AS A TRIAGING TOOL TO UPPER GI ENDOSCOPY DURING COVID-19 PANDEMIC

Massimiliano di Pietro  et al.

MULTISPECTRAL ENDOSCOPY FOR EARLY DETECTION OF DYSPLASIA IN BARRETT'S OESOPHAGUS: A FIRST-IN-HUMAN PILOT STUDY
MULTISPECTRAL ENDOSCOPY FOR EARLY DETECTION OF DYSPLASIA IN BARRETT'S OESOPHAGUS: A FIRST-IN-HUMAN PILOT STUDY

Massimiliano di Pietro  et al.

RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL
RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL

Massimiliano di Pietro  et al.

MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES

Massimiliano di Pietro  et al.

CYTOSPONGE-TFF3 TESTING CAN DETECT PRE-CANCEROUS MUCOSAL CHANGES OF THE STOMACH
CYTOSPONGE-TFF3 TESTING CAN DETECT PRE-CANCEROUS MUCOSAL CHANGES OF THE STOMACH

Massimiliano di Pietro  et al.

DEFINING THE OPTIMAL TREATMENT APPROACH FOR EARLY NEOPLASIA OF THE GASTROESOPHAGEAL JUNCTION: A MULTI-CENTER RETROSPECTIVE STUDY
DEFINING THE OPTIMAL TREATMENT APPROACH FOR EARLY NEOPLASIA OF THE GASTROESOPHAGEAL JUNCTION: A MULTI-CENTER RETROSPECTIVE STUDY

Massimiliano di Pietro  et al.

DEVELOPMENT AND VALIDATION OF ENDOSCOPIC CLASSIFICATION FOR SUPERFICIAL MUCOSAL LESIONS IN HEREDITARY DIFFUSE GASTRIC CANCER (HDGC)
DEVELOPMENT AND VALIDATION OF ENDOSCOPIC CLASSIFICATION FOR SUPERFICIAL MUCOSAL LESIONS IN HEREDITARY DIFFUSE GASTRIC CANCER (HDGC)

Massimiliano di Pietro  et al.

SIMPLE CYTOSPONGE-BIOMARKER TECHNOLOGY TO PRIORITIZE ENDOSCOPIC BARRETT’S ESOPHAGUS SURVEILLANCE
SIMPLE CYTOSPONGE-BIOMARKER TECHNOLOGY TO PRIORITIZE ENDOSCOPIC BARRETT’S ESOPHAGUS SURVEILLANCE

Massimiliano di Pietro  et al.

THE ROLE OF RANDOM BIOPSIES IN EARLY DIAGNOSIS OF SIGNET RING CELL CARCINOMA IN HEREDITARY DIFFUSE GASTRIC CANCER SYNDROME: A 16-YEAR LONGITUDINAL PROSPECTIVE STUDY
THE ROLE OF RANDOM BIOPSIES IN EARLY DIAGNOSIS OF SIGNET RING CELL CARCINOMA IN HEREDITARY DIFFUSE GASTRIC CANCER SYNDROME: A 16-YEAR LONGITUDINAL PROSPECTIVE STUDY

Massimiliano di Pietro  et al.

ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY
ENDOSCOPIC SURVEILLANCE IN AN EXPERT BARRETT’S CENTRE ASSOCIATES WITH HIGH DETECTION OF EARLY NEOPLASIA AND LOW DISEASE-SPECIFIC MORTALITY

Massimiliano di Pietro  et al.

STRUCTURAL VARIANT EVENTS DOMINATE A MOLECULAR CONTINUUM IN THE PROGRESSION OF BARRETT'S OESOPHAGUS
STRUCTURAL VARIANT EVENTS DOMINATE A MOLECULAR CONTINUUM IN THE PROGRESSION OF BARRETT'S OESOPHAGUS

Massimiliano di Pietro  et al.

THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION
THE UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION

Massimiliano di Pietro  et al.

OUTCOMES FROM THE UK PURASTAT REGISTRY: A MULTICENTRE OBSERVATIONAL STUDY OF PURASTAT USE IN GASTROINTESTINAL BLEEDING
OUTCOMES FROM THE UK PURASTAT REGISTRY: A MULTICENTRE OBSERVATIONAL STUDY OF PURASTAT USE IN GASTROINTESTINAL BLEEDING

Massimiliano di Pietro  et al.

P53 IMMUNOHISTOCHEMISTRY IMPROVES THE INTER-OBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS AND REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSIS IN BARRETT´S ESOPHAGUS
P53 IMMUNOHISTOCHEMISTRY IMPROVES THE INTER-OBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS AND REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSIS IN BARRETT´S ESOPHAGUS

Massimiliano di Pietro  et al.

Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Massimiliano di Pietro  et al.

FEASIBILITY OF THE CYTOSPONGE COUPLED WITH TISSUE BIOMARKERS IN EARLY DIAGNOSIS OF OESOPHAGEAL SQUAMOUS CELL CARCINOMA AND SURVEILLANCE OF HIGH-RISK INDIVIDUALS: PRELIMINARY RESULTS FROM THE EDEN STUDY
FEASIBILITY OF THE CYTOSPONGE COUPLED WITH TISSUE BIOMARKERS IN EARLY DIAGNOSIS OF OESOPHAGEAL SQUAMOUS CELL CARCINOMA AND SURVEILLANCE OF HIGH-RISK INDIVIDUALS: PRELIMINARY RESULTS FROM THE EDEN STUDY

Massimiliano di Pietro  et al.

OPTIMAL PROCEDURAL TIME ENSURES ADHERENCE TO SEATTLE PROTOCOL AND MAXIMIZES DYSPLASIA DETECTION IN BARRETT’S ESOPHAGUS SURVEILLANCE
OPTIMAL PROCEDURAL TIME ENSURES ADHERENCE TO SEATTLE PROTOCOL AND MAXIMIZES DYSPLASIA DETECTION IN BARRETT’S ESOPHAGUS SURVEILLANCE

Massimiliano di Pietro  et al.

Item 1 - 19 / 19
1